S&P 500 7,609.78 +0.13% NASDAQ 27,093.90 +0.03% DOW 51,307.79 +0.45% R2K 2,931.96 +0.90% VIX 15.77 -1.74%
N

Compare tickers

Up to 5 tickers, ~30 metrics, weighted verdict. Best in green, worst in red.

Verdict
Weighted score 0-100 across 1 tickers · best in green
#1
ABBV
score 50.0
Forward PE of 13.3 dominates with exceptional value despite negative momentum dragging down overall rank with -7.89% three-month decline.
value 50growth 50quality 50momentum 50sentiment 50
ABBV
AbbVie Inc.
$215.40
+1.16%
Snapshot
Price 215.4
Day % 1.16
1M % 4.26
3M % -7.89
YTD % -6.07
Market cap 380567158784.0
ADV ($) 1431345883.4417725
Beta 0.305
Tao zone
Current zone Neutral
Dist 21-EMA % 1.63
Dist ATR (σ) 0.64
Tao grade C
Confluence 2
Valuation
P/E (ttm) 105.588234
P/E (fwd) 13.271906
P/S 6.0581536
EV/EBITDA 14.701
P/B -57.18078
FCF yield 0.0547
PEG 0.59
Growth
Revenue yoy 0.124
EPS yoy -0.462
FCF yoy
Quality
Gross margin 0.72026
Operating margin 0.32156
Net margin 0.05786
ROE
ROA 0.10032
Debt / Equity
Interest cov. 3.28
Technicals
RSI(14) 56.4
MACD signal bull
vs 50-DMA 3.28
vs 200-DMA -1.96
vs 52w high -12.01
HV-30 23.3
Sentiment
Analyst rec 1.75
Target upside 17.41
Insider buy-sell 90d
Risk
Short interest 1.4199998999999999
Days to cover 3.39
Next earnings 2026-07-30
Full ABBV dashboard →